🎗Bridgestone Announces Start of Joint Development with TMDU a Walking Training Machine to Improve Senior Health
💊Opdivo (nivolumab) Demonstrates Superior Three-Year Survival Benefit for Patients with Previously Treated Advanced Renal Cell Carcinoma (RCC)